The journal of sexual medicine · 2011
The importance of follow-up in patients with premature ejaculation.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Moncada Ignacio
Аннотация
INTRODUCTION: Follow-up is an important aspect of managing patients with premature ejaculation (PE). However, there is limited information for the clinician on the optimal follow-up regimen in men with PE. At present, follow-up remains largely at the discretion of each treating physician.
AIM: The aim of this study was to provide an overview of follow-up in patients with PE.
METHODS: This study used a review of the literature and informed expert opinion.
MAIN OUTCOME MEASURES: The main outcome measures used by the study are the factors influencing follow-up in PE.
RESULTS: Following up with the patient is important to reconfirm the diagnosis, assess the patient's progress on treatment, monitor efficacy and side effects and, where necessary, make informed adjustments to treatment. In addition, follow-up sessions provide an opportunity to reeducate the patient, check that they remember the key information, fill in missing gaps in knowledge, and ensure that they are adhering to the correct dosing schedule. The frequency and duration of follow-up visits depend on a number of factors, such as the type and severity of PE, type of treatment, durability of response to PE treatment, the presence of comorbidities and individual partner/partnership issues. A cooperative and interested partner often has positive effects on treatment outcomes. Therefore, the partner should be encouraged to attend follow-up sessions for a better understanding of the impact of PE on their relationship and tailoring the treatment to suit the couple as a whole.
CONCLUSIONS: In clinical practice, follow-up forms an essential component of the overall management of PE to help ensure optimal treatment outcomes.
AIM: The aim of this study was to provide an overview of follow-up in patients with PE.
METHODS: This study used a review of the literature and informed expert opinion.
MAIN OUTCOME MEASURES: The main outcome measures used by the study are the factors influencing follow-up in PE.
RESULTS: Following up with the patient is important to reconfirm the diagnosis, assess the patient's progress on treatment, monitor efficacy and side effects and, where necessary, make informed adjustments to treatment. In addition, follow-up sessions provide an opportunity to reeducate the patient, check that they remember the key information, fill in missing gaps in knowledge, and ensure that they are adhering to the correct dosing schedule. The frequency and duration of follow-up visits depend on a number of factors, such as the type and severity of PE, type of treatment, durability of response to PE treatment, the presence of comorbidities and individual partner/partnership issues. A cooperative and interested partner often has positive effects on treatment outcomes. Therefore, the partner should be encouraged to attend follow-up sessions for a better understanding of the impact of PE on their relationship and tailoring the treatment to suit the couple as a whole.
CONCLUSIONS: In clinical practice, follow-up forms an essential component of the overall management of PE to help ensure optimal treatment outcomes.